Phage M13 for the treatment of Alzheimer and Parkinson disease

Gene

Volumn 583, Issue 2, 2016, Pages 85-89

  Messing, Joachim ^a  

^a RUTGERS UNIVERSITY   (United States)

Author keywords

Alzheimer disease; Bacteriophage M13; Parkinson disease

Indexed keywords

AMYLOID; SYNUCLEIN; AMYLOID BETA PROTEIN; PREALBUMIN; PRION; PROTEIN BINDING; TAU PROTEIN; VIRUS PROTEIN;

ALZHEIMER DISEASE; CLONING VECTOR; ENTEROBACTERIA PHAGE M13; LIFE CYCLE; NONHUMAN; PARKINSON DISEASE; PHAGE DISPLAY; PRIORITY JOURNAL; REVIEW; ANTAGONISTS AND INHIBITORS; BIOLOGICAL THERAPY; BIOSYNTHESIS; CELL SURFACE DISPLAY; CHEMISTRY; ESCHERICHIA COLI; GENE EXPRESSION; GENETICS; HUMAN; METABOLISM; PATHOLOGY; PHYSIOLOGY; PLAQUE, AMYLOID; PRION; PROCEDURES; PROTEIN AGGREGATION, PATHOLOGICAL; VIROLOGY;

ALZHEIMER DISEASE; AMYLOID BETA-PEPTIDES; BACTERIOPHAGE M13; BIOLOGICAL THERAPY; CELL SURFACE DISPLAY TECHNIQUES; ESCHERICHIA COLI; GENE EXPRESSION; HUMANS; PARKINSON DISEASE; PLAQUE, AMYLOID; PREALBUMIN; PRIONS; PROTEIN AGGREGATION, PATHOLOGICAL; PROTEIN BINDING; SYNUCLEINS; TAU PROTEINS; VIRAL PROTEINS;

EID: 84959043869     PISSN: 03781119     EISSN: 18790038     Source Type: Journal    
DOI: 10.1016/j.gene.2016.02.005     Document Type: Review

References (32)

1. Argyri L., Dafnis I., Theodossiou T.A., Gantz D., Stratikos E., Chroni A. Molecular basis for increased risk for late-onset Alzheimer disease due to the naturally occurring L28P mutation in apolipoprotein E4. J. Biol. Chem. 2014, 289:12931-12945.
2. Bard F., Barbour R., Cannon C., Carretto R., Fox M., Games D., Guido T., Hoenow K., Hu K., Johnson-Wood K., Khan K., Kholodenko D., Lee C., Lee M., Motter R., Nguyen M., Reed A., Schenk D., Tang P., Vasquez N., Seubert P., Yednock T. Epitope and isotype specificities of antibodies to beta -amyloid peptide for protection against Alzheimer's disease-like neuropathology. Proc. Natl. Acad. Sci. U. S. A. 2003, 100:2023-2028.
3. Benzinger R., Delius H., Janenisch R., Hofschneider P.H. Infectious nucleic acids of Escherichia coli bacteriophages. 10. Preparation and properties of Escherichia coli competent for infectious DNA from bacteriophages phi X 174 and M 13 and RNA from bacteriophage M 12. Eur. J. Biochem. 1967, 2:414-428.
4. Dimant H., Solomon B. Filamentous phages reduce alpha-synuclein oligomerization in the membrane fraction of SH-SY5Y cells. Neurodegener. Dis. 2010, 7:203-205.
5. Dimant H., Sharon N., Solomon B. Modulation effect of filamentous phage on alpha-synuclein aggregation. Biochem. Biophys. Res. Commun. 2009, 383:491-496.
6. Doudna J.A., Charpentier E. Genome editing. The new frontier of genome engineering with CRISPR-Cas9. Science 2014, 346:1258096.
7. Eckert B., Schmid F.X. A conformational unfolding reaction activates phage fd for the infection of Escherichia coli. J. Mol. Biol. 2007, 373:452-461.
8. Eckert B., Martin A., Balbach J., Schmid F.X. Prolyl isomerization as a molecular timer in phage infection. Nat. Struct. Mol. Biol. 2005, 12:619-623.
9. Findley L.J. The economic impact of Parkinson's disease. Parkinsonism Relat. Disord. 2007, 13:S8-S12. (Suppl).
10. Frenkel D., Katz O., Solomon B. Immunization against Alzheimer's beta-amyloid plaques via EFRH phage administration. Proc. Natl. Acad. Sci. U. S. A. 2000, 97:11455-11459.
11. Gronenborn B., Messing J. Methylation of single-stranded DNA in vitro introduces new restriction endonuclease cleavage sites. Nature 1978, 272:375-377.
12. Henry T.J., Pratt D. The proteins of bacteriophage M13. Proc. Natl. Acad. Sci. U. S. A. 1969, 62:800-807.
13. Hoffmann-Thoms S., Weininger U., Eckert B., Jakob R.P., Koch J.R., Balbach J., Schmid F.X. Initiation of phage infection by partial unfolding and prolyl isomerization. J. Biol. Chem. 2013, 288:12979-12991.
14. Kaiser J. BIOMEDICAL RESEARCH. Spending bills put NIH on track for biggest raise in 12 years. Science 2015, 349:12-13.
15. Krishnan R., Tsubery H., Proschitsky M.Y., Asp E., Lulu M., Gilead S., Gartner M., Waltho J.P., Davis P.J., Hounslow A.M., Kirschner D.A., Inouye H., Myszka D.G., Wright J., Solomon B., Fisher R.A. A bacteriophage capsid protein provides a general amyloid interaction motif (GAIM) that binds and remodels misfolded protein assemblies. J. Mol. Biol. 2014, 426:2500-2519.
16. Ksendzovsky A., Walbridge S., Saunders R.C., Asthagiri A.R., Heiss J.D., Lonser R.R. Convection-enhanced delivery of M13 bacteriophage to the brain. J. Neurosurg. 2012, 117:197-203.
17. Lin N.S., Pratt D. Role of bacteriophage M13 gene 2 in viral DNA replication. J. Mol. Biol. 1972, 72:37-49.
18. Linderoth N.A., Simon M.N., Russel M. The filamentous phage pIV multimer visualized by scanning transmission electron microscopy. Science 1997, 278:1635-1638.
19. Lundqvist C., Beiske A.G., Reiertsen O., Kristiansen I.S. Real life cost and quality of life associated with continuous intraduodenal levodopa infusion compared with oral treatment in Parkinson patients. J. Neurol. 2014, 261:2438-2445.
20. Messing J. A multipurpose cloning system based on the single-stranded DNA bacteriophage M13. Recomb. DNA Tech. Bull. 1979, 79-99:43-48. NIH Publication.
21. Messing J., Gronenborn B., Müller-Hill B., Hans Hopschneider P. Filamentous coliphage M13 as a cloning vehicle: insertion of a HindII fragment of the lac regulatory region in M13 replicative form in vitro. Proc. Natl. Acad. Sci. U. S. A. 1977, 74:3642-3646.
22. Reitz C., Mayeux R. Alzheimer disease: epidemiology, diagnostic criteria, risk factors and biomarkers. Biochem. Pharmacol. 2014, 88:640-651.
23. Schroder C.H., Erben E., Kaerner H.C. A rolling circle model of the in vivo replication of bacteriophage phiX174 replicative form DNA: different fate of two types of progeny replicative form. J. Mol. Biol. 1973, 79:599-613.
24. Sheridan C. Pivotal trials for beta-secretase inhibitors in Alzheimer's. Nat. Biotechnol. 2015, 33:115-116.
25. Smith G.P. Surface presentation of protein epitopes using bacteriophage expression systems. Curr. Opin. Biotechnol. 1991, 2:668-673.
26. Staudenbauer W.L., Hofschneider P.H. Replication of bacteriophage M-13. Positive role of gene-5 protein in single-strand-DNA synthesis. Eur. J. Biochem. 1973, 34:569-576.
27. Sun T.P., Webster R.E. Fii, a bacterial locus required for filamentous phage infection and its relation to colicin-tolerant tolA and tolB. J. Bacteriol. 1986, 165:107-115.
28. Waksman S.A. Microbiology as a field of science and application. Am. Sci. 1969, 57:364-371.
29. Wan Z., Goddard N.L. Competition between conjugation and M13 phage infection in Escherichia coli in the absence of selection pressure: a kinetic study. G3 (Bethesda) 2012, 2:1137-1144.
30. Wirtz A., Hofschneider P.H. Replication of the single stranded DNA bacteriophage M 13. Intracellular flow of parental DNA and transfer to progeny particles. Eur. J. Biochem. 1970, 17:141-150.
31. Yamakawa H., Yagishita S., Futai E., Ishiura S. Beta-secretase inhibitor potency is decreased by aberrant beta-cleavage location of the "Swedish mutant" amyloid precursor protein. J. Biol. Chem. 2010, 285:1634-1642.
32. Yanisch-Perron C., Vieira J., Messing J. Improved M13 phage cloning vectors and host strains: nucleotide sequences of the M13mp18 and pUC19 vectors. Gene 1985, 33:103-119.